Cargando…
Comparison of outcomes between metaplastic and triple-negative breast cancer patients
PURPOSE: Metaplastic breast cancer (MBC) is a rare, aggressive variant of breast cancer that has been associated with poor clinical outcomes, as has triple-negative breast (TNBC) cancer. Limited studies compare the clinical characteristics and prognosis of MBC to TNBC. This study uses a large, conte...
Autores principales: | Polamraju, Praveen, Haque, Waqar, Cao, Kevin, Verma, Vivek, Schwartz, Mary, Klimberg, V. Suzanne, Hatch, Sandra, Niravath, Polly, Butler, E. Brian, Teh, Bin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375639/ https://www.ncbi.nlm.nih.gov/pubmed/31675684 http://dx.doi.org/10.1016/j.breast.2019.10.003 |
Ejemplares similares
-
The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast
por: Lewis, Gary. D., et al.
Publicado: (2021) -
Chemotherapy Versus Chemoradiation for Node-Positive Bladder Cancer: Practice Patterns and Outcomes from the National Cancer Data Base
por: Haque, Waqar, et al.
Publicado: (2017) -
Clinical value of R-spondins in triple-negative and metaplastic breast cancers
por: Coussy, F, et al.
Publicado: (2017) -
Complete Response of Triple-Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab
por: Ladwa, Amrita, et al.
Publicado: (2023) -
The Role of Adjuvant Radiation Therapy in Locally Advanced Bladder Cancer
por: Lewis, Gary D., et al.
Publicado: (2018)